Ablevia Biotech
Ablevia develops therapeutics for removal of undesired and disease-causing antibodies in rare diseases and conditions with unmet clinical needs.
Toggle Navigation
- ResearchBack
- Research at Vienna BioCenter
- Research Areas
- Research Groups
- Key Discoveries
- Recent Research Highlights
- Research Entities
- Biotech Companies
- Facilities
- Events
- Career
- Facilities
Back- Companies
Back- Companies at Vienna BioCenter
- Biotech CompaniesBack
- a:head
- Ablevia Biotech (current)
- ACCANIS Biotech
- Aelian Biotechnology
- Affiris
- Akribes
- Allcyte
- Apeiron Biologics
- Ares Genetics
- Austrianni
- Bird-C
- ChanPharm
- EUCODIS Bioscience
- Eveliqure
- Haplogen
- Hookipa Pharma
- Lexogen
- Miti Biosystems
- Origimm
- PhagoMed
- ScarletRed
- The Antibody Lab
- Thermo Fisher Scientific
- Valneva
- X4 Pharmaceuticals
- Service Companies
- Business IncubatorBack
- Scientific AssociationBack
- Education
- Career